can you take semaglutide with kidney disease just got FDA-approved for disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney progression in Semaglutide in Diabetic Kidney Disease:

In 2013, this compound was reported to have both anti-diabetic and anti-obesity effects, with its anti-obesity efficacy surpassing that of GLP-1RAs [25]

DOI: 10.1056/NEJMoa2416394

Taspoglutide prevents apoptosis in vitro , promotes -cell proliferation, and exerts multiple protective effects of -cell in Zucker Diabetic Fatty rats [20]

By simultaneously activating GIP, GLP-1, and glucagon receptors, the peptide orchestrates a comprehensive metabolic response that addresses various aspects of energy homeostasis and glucose regulation

The three components and their documented roles: Anchor-compound logic

What this means for current drop users Users currently taking compounded oral tirzepatide drops should recognize that the products they use today are essentially placeholder versions of what pharmaceutical companies are working to develop properly